Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer

scientific article published on 01 March 2007

Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.IJROBP.2006.09.056
P698PubMed publication ID17293229

P50authorEzra E CohenQ38641744
Everett E VokesQ73567428
Daniel J HarafQ107320209
P2093author name stringJean Bourhis
Elwyn Loh
Dominique Rosine
Liji Shen
Antoine Lusinchi
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectcisplatinQ412415
head and neck cancerQ1783924
phase I clinical trialQ5452194
head and neck carcinomaQ18554836
neck cancerQ18966654
P304page(s)678-684
P577publication date2007-03-01
P1433published inInternational Journal of Radiation Oncology Biology PhysicsQ2296252
P1476titlePhase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer
P478volume67

Reverse relations

cites work (P2860)
Q53187323A two-year dietary carcinogenicity study of cyadox in Sprague-Dawley rats.
Q37450696Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer
Q48378461Carotid blowout in patients with head and neck cancer: associated factors and treatment outcomes
Q41480144Hypoxia in head and neck squamous cell carcinoma
Q43137324Local Tumor Control and Normal Tissue Toxicity of Pulsed Low-Dose Rate Radiotherapy for Recurrent Lung Cancer: An In Vivo Animal Study.
Q36783381Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo Clinic
Q46917593Palliative radiation therapy for head and neck cancer: toward an optimal fractionation scheme
Q35611873Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC).
Q84357377Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation
Q26752388Quinoxaline 1,4-di-N-Oxides: Biological Activities and Mechanisms of Actions
Q38183707Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate
Q35839993Simple carotid-sparing intensity-modulated radiotherapy technique and preliminary experience for T1-2 glottic cancer

Search more.